Research Roundup

Debbie Rigby rounds up the latest in research news Comparative Effectiveness and Safety of LAMA-LABA Inhalers in Chronic Obstructive Pulmonary Disease In this active comparator new-user cohort study of 55 817 matched pairs, once-daily umeclidinium-vilanterol dry powder inhalers were associated with a 14% lower hazard of moderate or severe COPD exacerbations than twice-daily glycopyrrolate-formoterol metered-dose inhalers